Exicure
Business Services · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2430 N Halsted St, Chicago, Illinois, 60...Phone Number
(847) 673-1700Website
www.exicuretx.comRevenue
<$5 MillionStock Symbol
XCURIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Exicure
Exicure, Inc. is a development-stage biotechnology company developing therapeutics for neurology and other genetic disorders based on its proprietary Spherical Nucleic Acid, or SNA, technology. Exicure believes that its proprietary SNA architecture has distinct chemical and biological properties that may provide advantages over other nucleic acid therapeutics and may have therapeutic potential to target diseases not typically addressed with other nucleic acid therapeutics. Exicure is based in Chicago, IL.Explore more
Exicure Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Exicure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Exicure recently announced quarterly report
Exicure, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Exicure has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Exicure launches new products
Click to see if Exicure had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Exicure has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Exicure is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Exicure
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Exicure
Compare insights from companies similar to Exicure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Exicure is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Exicure is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Exicure.
Exicure financials insights
Gather financial insights about Exicure, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series B
$5.4M
2014
Series C
$13.6M
2015
Other Financing Round
$14.8M
2017
Share Placement
$20M
Share Placement
$11.2M
2020
Debt
$350K
Debt
$25M
2022
Private Equity
$5.4M
2024
Private Equity
$10M
Share Placement
$8.7M
Exicure Tech Stack
A closer look at the technologies used by Exicure
See more technologies
Most Recent Scoops
Executive Move
Executive Moves
Project
Product Management, Intellectual Property, Legal Affairs, Governmental Affairs & Regulation, Clinical Operations
Promotion
Executive Move
Executive Moves, Promotion
Funding
Funding
Funding
Funding
Exicure News & Media
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
Exicure announced receipt of a Nasdaq notice related to the delayed filing of its Form 10-Q and confirmed that the Form 10-Q was filed on May 29, 2026.Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
Exicure enters co-development agreement with Adbiotech to advance Burixafor (GPC-100) combination therapies across multiple indications.Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative ActionsExicure, Inc. Reports Full Year 2025 Financial Results
Exicure, Inc. Reports Full Year 2025 Financial Results
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Exicure
Sign Up For FreeTo access detailed company insights
Exicure, Inc. is a development-stage biotechnology company developing therapeutics for neurology and other genetic disorders based on its proprietary Spherical Nucleic Acid, or SNA, technology. Exicure believes that its proprietary SNA architecture has distinct chemical and biological properties that may provide advantages over other nucleic acid t... Read More
